2180 related articles for article (PubMed ID: 17957097)
1. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
2. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
3. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
4. Alpha-interferon therapy increases serum beta2-microglobulin levels in hemodialysis patients.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Navarro MD; Aljama P
Clin Nephrol; 2001 Nov; 56(5):378-81. PubMed ID: 11758008
[TBL] [Abstract][Full Text] [Related]
5. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
Haufe CC; Eismann U; Deppisch RM; Stein G
Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
[TBL] [Abstract][Full Text] [Related]
6. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
Szepietowski T; el-Hayek A
Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis.
Gerdemann A; Lemke HD; Nothdurft A; Heidland A; Münch G; Bahner U; Schinzel R
Clin Nephrol; 2000 Oct; 54(4):276-83. PubMed ID: 11076103
[TBL] [Abstract][Full Text] [Related]
8. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
Krieter DH; Lemke HD; Wanner C
Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
[TBL] [Abstract][Full Text] [Related]
9. Effect of the hemodialysis membrane on the inflammatory reaction in vivo.
Schindler R; Boenisch O; Fischer C; Frei U
Clin Nephrol; 2000 Jun; 53(6):452-9. PubMed ID: 10879665
[TBL] [Abstract][Full Text] [Related]
10. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
[TBL] [Abstract][Full Text] [Related]
11. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
13. The effect of high-flux hemodialysis on renal anemia.
Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
[TBL] [Abstract][Full Text] [Related]
14. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
[TBL] [Abstract][Full Text] [Related]
15. The effect of high-flux hemodialysis on dialysis-associated amyloidosis.
Ayli M; Ayli D; Azak A; Yüksel C; Atilgan G; Dede F; Akalin T; Abayli E; Camlibel M
Ren Fail; 2005; 27(1):31-4. PubMed ID: 15717632
[TBL] [Abstract][Full Text] [Related]
16. Beta-2 microglobulin levels in hemodialysis patients.
Mumtaz A; Anees M; Bilal M; Ibrahim M
Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):701-6. PubMed ID: 20587875
[TBL] [Abstract][Full Text] [Related]
17. [LEVEL AND OXIDATION OF BETA 2-MICROGLOBULIN IN HEMODIALYSIS PATIENTS TREATED WITH INTRAVENOUS IRON DURING DIALYSIS WITH HIGH-FLUX COMPARED TO LOW-FLUX DIALYZERS].
Michelis R; Sela S; Lanzmann A; Tanchilevski O; Shurtz-Swirski R; Kristal B
Harefuah; 2017 May; 156(5):289-293. PubMed ID: 28551910
[TBL] [Abstract][Full Text] [Related]
18. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
[TBL] [Abstract][Full Text] [Related]
19. The role of dialyzer membrane flux in bio-incompatibility.
Davenport A
Hemodial Int; 2008 Oct; 12 Suppl 2():S29-33. PubMed ID: 18837767
[TBL] [Abstract][Full Text] [Related]
20. [Factors which influence phosphorus removal in hemodialysis].
Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
